Skip to content

Screener

Eligibility screening

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

Sponsored by Janssen Research & Development, LLCStudy detailsClinicalTrials.gov

23 US sites in AZ, CA, FL, GA +10

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.